Pharma Times

OCTOBER 4, 2022

University of Lincoln and the University of Sheffield are researching how DNA could be repaired

DNA 167

DNA Research 167

Medical Xpress

MARCH 29, 2025

Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial vaginosis (BV) during their lifetime. BV is characterized by unpleasant odors, and potentially painful side effects, as well as the risk of associated health issues later in life.

DNA 123

DNA Development Research Genetics 123

Pharma Times

MAY 10, 2023

Transfer marks start of vital development stage as company expands its range of synthesized DNA

DNA 152

DNA Development 152

Bio Pharma Dive

JULY 1, 2024

Ensure the safety of gene therapies with accurate HEK293 DNA measurement using Vericheck ddPCR kits.

DNA 144

DNA Gene Therapy Gene 144

Bio Pharma Dive

JANUARY 4, 2024

Moonwalk Biosciences, the latest biotech cofounded by the gene editing scientist, joins other startups aiming to alter gene expression without changing DNA.

Gene Editing 351

Gene Editing Gene Expression DNA Gene 351

Pharma Mirror

JANUARY 2, 2024

The popularity of at-home DNA testing is soaring in popularity and uses. When someone seeks information about paternity or genetic diseases without visiting a doctor’s chamber or laboratory, the best alternative is the at-home DNA test kit. The question which concerns everyone is, ‘are home DNA test kits accurate?’.

DNA 130

DNA Genetic Disease Genetics 130

Bio Pharma Dive

MARCH 23, 2021

A disappointing recommendation from outside data reviewers raises doubts about the DNA-targeting drug's benefits and puts pressure on Roche's partner, Ionis Pharmaceuticals.

DNA 347

DNA Drugs 347

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 1, 2023

The Drug Controller General of India (DCGI) has added in-vitro diagnostic (IVD) medical devices including those for diagnosis of Covid-19, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) extraction kits, among others into the Class C risk category under the Medical Devices Rules (MDR), 2017.

RNA 189

RNA DNA In-Vitro Drugs 189

Outsourcing Pharma

DECEMBER 23, 2020

The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.

DNA 144

DNA Genome Genomics Development 144

Bio Pharma Dive

MAY 13, 2021

With $82 million in hand, Flare Therapeutics is looking to create precision cancer drugs by going after a type of protein called transcription factors.

DNA 247

DNA Regulation Protein Drugs 247

Bio Pharma Dive

OCTOBER 19, 2020

The trial would be the first test of a systemically administered gene editing treatment that uses the Nobel Prize-winning technology to alter DNA.

Gene Editing 326

Gene Editing DNA Gene Drugs 326

Bio Pharma Dive

JULY 26, 2022

Three startups have recently emerged with plans to edit the epigenome rather than DNA directly. Here’s why that matters and what they aim to do.

DNA 329

DNA 329

Bio Pharma Dive

DECEMBER 12, 2023

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genome 332

Genome Genomics DNA Genetics 332

Pharma Times

APRIL 2, 2025

GMP certification enables 4basebio to supply DNA for clinical trials

DNA 103

DNA Manufacturing Clinical Trials Clinical Trials 103

Bio Pharma Dive

NOVEMBER 17, 2021

Chroma Medicine's launch is the latest step in a decadeslong quest by drugmakers to capitalize on research into epigenetics, a way of controlling gene expression without altering DNA.

Gene Expression 322

Gene Expression DNA Gene Medicine 322

Bio Pharma Dive

MARCH 23, 2022

The deal, announced alongside a $175 million round, makes biotech entrepreneur Greg Verdine's startup the most well-funded among an emerging group of companies searching for drugs in fungal DNA.

DNA 322

DNA Drugs 322

Pharmaceutical Technology

SEPTEMBER 23, 2024

s groundbreaking patent for synthesizing specific DNA sequences. Discover Telesis Bio Inc.'s Learn how their innovative method enhances genetic engineering and biotechnology.

DNA 130

DNA Genetic Engineering Engineer Genetics 130

Pharmaceutical Technology

DECEMBER 7, 2023

Synplogen and Ginkgo Bioworks have signed an MOU to expedite DNA manufacturing and gene therapy platform services in Japan.

DNA 130

DNA Manufacturing Gene Therapy Gene 130

BioPharma Reporter

AUGUST 2, 2021

With Scancell taking its DNA-based COVID-19 vaccine tech into clinical trials this year, it is already focusing its attention on the techâs potential to be used as a needle-free booster shot to address Variants of Concern.

DNA 137

DNA Vaccine Vaccination Clinical Trials 137

pharmaphorum

JULY 12, 2024

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

DNA 111

DNA Marketing 111

Pharmaceutical Technology

APRIL 22, 2024

Discover how PMV Pharmaceuticals Inc's patented compounds restore DNA binding affinity of p53 mutants, aiding in tumor suppression and reducing cancer progression. Explore the specific formula and structural features outlined in the granted patent (Publication Number: US11926632B2).

DNA 130

DNA 130

Pharmaceutical Technology

APRIL 22, 2024

Detect cancer early with Eurofins' patented method analyzing cell-free DNA for methylated CpGs. Personalized treatment options outlined in recent patent.

DNA 130

DNA 130

Bio Pharma Dive

SEPTEMBER 28, 2020

The FDA has suspended the planned start of a late-stage trial of Inovio's experimental shot, dealing another setback to one of the most advanced DNA-based vaccine programs in development.

Vaccine 274

Vaccine Vaccination DNA Trials 274

Bio Pharma Dive

OCTOBER 25, 2022

“Every struggle that I've had has woven a sense of persistence into my DNA,” said Zhang, in a wide-ranging interview about leading a biotech startup as a young CEO.

Genome 274

Genome Genomics DNA Drugs 274

Bio Pharma Dive

APRIL 18, 2024

Company head Anne Wojcicki is considering buying all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

DNA 260

DNA 260

Pharmaceutical Technology

APRIL 30, 2024

Unlock the potential of genetic modification with Precision Biosciences Inc's patented MTEM technology for precise editing of eukaryotic cells. Discover how this mitochondria-targeting engineered meganuclease is revolutionizing genetic research.

Engineer 195

Engineer DNA Genetics Research 195

Bio Pharma Dive

OCTOBER 12, 2022

The startup, run by Translate Bio cofounder Romesh Subramanian, believes its RNA “exon editing” approach could have long-lasting effects without the risks that come with editing DNA.

RNA 261

RNA DNA 261

Bio Pharma Dive

SEPTEMBER 12, 2022

Scientists at Pretzel believe fixing mutated mitochondrial DNA with a mix of small molecule therapies and gene editing could be key to solving a number of hard-to-treat diseases.

Gene Editing 261

Gene Editing DNA Gene Scientist 261

STAT News

SEPTEMBER 16, 2022

Intellia Therapeutics said Friday the first six patients to receive its CRISPR-based treatment for a genetic swelling disorder have safely had small, corrective changes made to dysfunctional DNA inside their liver cells.

DNA 142

DNA Gene Editing In-Vivo Genetics 142

Medical Xpress

NOVEMBER 17, 2022

BRCA1 (BReast CAncer Gene 1), a key gene that becomes faulty in some instances, leading to breast and ovarian cancer, plays an important role in the body's DNA repair mechanisms. BRCA1, once mutated, can cause cancer to develop.

DNA 119

DNA Production Gene Development 119

BioPharma Reporter

JANUARY 24, 2024

We took the time to speak with Amy Walker, vice president at 4basebio, to discuss the merits of synthetic DNA and its future application.

DNA 100

DNA Development 100

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 24, 2024

It all started with research on a sugar that naturally occurs in the body and helps form DNA: the ‘deoxyribose‘ part of deoxyribonucleic acid. Earlier this year, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair loss in both men and women worldwide.

DNA 246

DNA Scientist Research Clinical Trials 246

AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 30, 2024

Silently tucked away in our genomes, some of these bits of foreign DNA can get passed down through the generations. When viruses pay us a visit, they sometimes leave parts of themselves behind. They were long thought inactive, but we’ve since learned these stowaway sequences can be turned back on to wreak all sorts of […]

DNA 243

DNA Gene Genome Genomics 243

pharmaphorum

SEPTEMBER 4, 2024

Swiss startup Haya Therapeutics has formed a $1bn partnership with Eli Lilly to look for new therapies for obesity in non-coding DNA

DNA 97

DNA Drugs 97

Medical Xpress

FEBRUARY 22, 2023

Mount Sinai researchers have published a study in Alzheimer's & Dementia: The Journal of the Alzheimer's Association that sheds new light on the role of DNA methylation in Alzheimer's disease (AD).

DNA 98

DNA Research Protein Gene 98

Medical Xpress

MAY 14, 2023

For two decades, scientists have been comparing every person's full set of DNA they study to a template that relies mostly on genetic material from one man affectionately known as "the guy from Buffalo."

DNA 98

DNA Scientist Genomics Genome 98

Fierce Pharma

JANUARY 4, 2023

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. Wed, 01/04/2023 - 06:37.

DNA 104

DNA Manufacturing 104